NCT06023966View on ClinicalTrials.gov

A Clinical Prospective Study to Validate a Risk Scoring Model for the HMGC After Curative Surgery

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

March 31, 2026

Conditions
Predictive Cancer ModelHepatic MetastasisGastric Cancer
Trial Locations (1)

300060

RECRUITING

Cancer Hospital of Tianjin Medical University, Tianjin

All Listed Sponsors
lead

Tianjin Medical University Cancer Institute and Hospital

OTHER